Advertisement
Screener

PALATIN TECHNOLOGIES, INC. (PTN) Operating Expenses

2.8 / 5 stars · 68/120 Roast Me

PALATIN TECHNOLOGIES, INC. Operating Expenses

PALATIN TECHNOLOGIES, INC. (PTN) reported Operating Expenses of $5.50 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-13.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:OperatingExpenses · last filed 2026-05-13

  • PALATIN TECHNOLOGIES, INC. operating expenses for the quarter ending 2026-03-31 was $5.50M, a 14.30% increase year-over-year.
  • PALATIN TECHNOLOGIES, INC. operating expenses for the quarter ending 2025-12-31 was $7.44M, a 185.09% increase year-over-year.
  • PALATIN TECHNOLOGIES, INC. operating expenses for the quarter ending 2025-09-30 was $4.19M, a 46.08% decline year-over-year.
  • PALATIN TECHNOLOGIES, INC. operating expenses for the quarter ending 2025-06-30 was $2.27M, a 73.88% decline year-over-year.
  • PALATIN TECHNOLOGIES, INC. operating expenses for fiscal 2025 was $17.46M, a 35.30% decline from fiscal 2024.
  • PALATIN TECHNOLOGIES, INC. operating expenses for fiscal 2024 was $26.99M, a 27.68% decline from fiscal 2023.
  • PALATIN TECHNOLOGIES, INC. operating expenses for fiscal 2023 was $37.31M, a 1.96% decline from fiscal 2022.
  • PALATIN TECHNOLOGIES, INC. operating expenses for fiscal 2022 was $38.06M, a 14.64% increase from fiscal 2021.
Period endOperating Expenses 3 monthOperating Expenses 3 month as first filedOperating Expenses 6 monthOperating Expenses 9 monthOperating Expenses 12 monthOperating Expenses 12 month as first filed
2026-03-31$5.50M
10-Q · filed 2026-05-13
$12.95M
derived: sum of 2 quarters · filed 2026-05-13
$17.13M
10-Q · filed 2026-05-13
$19.40M
derived: sum of 4 quarters · filed 2026-05-13
2025-12-31$7.44M
10-Q · filed 2026-02-17
$11.63M
10-Q · filed 2026-02-17
$13.90M
derived: sum of 3 quarters · filed 2026-02-17
$18.72M
derived: sum of 4 quarters · filed 2026-05-13
2025-09-30$4.19M
10-Q · filed 2025-11-14
$6.46M
derived: sum of 2 quarters · filed 2025-11-14
$11.27M
derived: sum of 3 quarters · filed 2026-05-13
$13.88M
derived: sum of 4 quarters · filed 2026-05-13
2025-06-30$2.27M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23
$7.08M
derived: sum of 2 quarters · filed 2026-05-13
$9.70M
derived: sum of 3 quarters · filed 2026-05-13
$17.46M
10-K · filed 2025-09-23
2025-03-31$4.81M
10-Q · filed 2026-05-13
$7.42M
derived: sum of 2 quarters · filed 2026-05-13
$15.19M
10-Q · filed 2026-05-13
$23.88M
derived: sum of 4 quarters · filed 2026-05-13
2024-12-31$2.61M
10-Q · filed 2026-02-17
$10.38M
10-Q · filed 2026-02-17
$19.07M
derived: sum of 3 quarters · filed 2026-02-17
$28.29M
derived: sum of 4 quarters · filed 2026-02-17
2024-09-30$7.76M
10-Q · filed 2025-11-14
$16.46M
derived: sum of 2 quarters · filed 2025-11-14
$25.68M
derived: sum of 3 quarters · filed 2025-11-14
$26.54M
derived: sum of 4 quarters · filed 2025-11-14
2024-06-30$8.69M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23
$17.91M
derived: sum of 2 quarters · filed 2025-09-23
$18.77M
derived: sum of 3 quarters · filed 2025-09-23
$26.99M
10-K · filed 2025-09-23
2024-03-31$9.22M
10-Q · filed 2025-05-14
$10.08M
derived: sum of 2 quarters · filed 2025-05-14
$18.29M
10-Q · filed 2025-05-14
$30.87M
derived: sum of 4 quarters · filed 2025-05-14
2023-12-31$860.97K
10-Q · filed 2025-02-13
$9.08M
10-Q · filed 2025-02-13
$21.66M
derived: sum of 3 quarters · filed 2025-02-13
$30.15M
derived: sum of 4 quarters · filed 2025-02-13
2023-09-30$8.21M
10-Q · filed 2024-11-14
$20.79M
derived: sum of 2 quarters · filed 2024-11-14
$29.29M
derived: sum of 3 quarters · filed 2024-11-14
$35.91M
derived: sum of 4 quarters · filed 2024-11-14
2023-06-30$12.58M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-30
$21.08M
derived: sum of 2 quarters · filed 2024-09-30
$27.69M
derived: sum of 3 quarters · filed 2024-09-30
$37.31M
10-K · filed 2024-09-30
2023-03-31$8.50M
10-Q · filed 2024-05-15
$15.11M
derived: sum of 2 quarters · filed 2024-05-15
$24.73M
10-Q · filed 2024-05-15
$38.60M
derived: sum of 4 quarters · filed 2024-05-15
2022-12-31$6.61M
10-Q · filed 2024-02-14
$16.24M
10-Q · filed 2024-02-14
$30.11M
derived: sum of 3 quarters · filed 2024-02-14
$38.14M
derived: sum of 4 quarters · filed 2024-02-14
2022-09-30$9.62M
10-Q · filed 2023-11-14
$23.49M
derived: sum of 2 quarters · filed 2023-11-14
$31.53M
derived: sum of 3 quarters · filed 2023-11-14
$40.30M
derived: sum of 4 quarters · filed 2023-11-14
2022-06-30$13.87M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-28
$21.91M
derived: sum of 2 quarters · filed 2023-09-28
$30.68M
derived: sum of 3 quarters · filed 2023-09-28
$38.06M
10-K · filed 2023-09-28
2022-03-31$8.04M
10-Q · filed 2023-05-15
$16.81M
derived: sum of 2 quarters · filed 2023-05-15
$24.19M
10-Q · filed 2023-05-15
$38.06M
derived: sum of 4 quarters · filed 2023-05-15
2021-12-31$8.77M
10-Q · filed 2023-02-14
$16.15M
10-Q · filed 2023-02-14
$30.03M
derived: sum of 3 quarters · filed 2023-02-14
$36.60M
derived: sum of 4 quarters · filed 2023-02-14
2021-09-30$7.38M
10-Q · filed 2022-11-14
$21.25M
derived: sum of 2 quarters · filed 2022-11-14
$27.83M
derived: sum of 3 quarters · filed 2022-11-14
$36.91M
derived: sum of 4 quarters · filed 2022-11-14
2021-06-30$13.88M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-22
$20.45M
derived: sum of 2 quarters · filed 2022-09-22
$29.54M
derived: sum of 3 quarters · filed 2022-09-22
$33.20M
10-K · filed 2022-09-22
2021-03-31$6.57M
10-Q · filed 2022-05-16
$15.66M
derived: sum of 2 quarters · filed 2022-05-16
$19.32M
10-Q · filed 2022-05-16
$26.71M
derived: sum of 4 quarters · filed 2022-05-16
2020-12-31$9.09M
10-Q · filed 2022-02-14
$12.74M
10-Q · filed 2022-02-14
$20.13M
derived: sum of 3 quarters · filed 2022-02-14
$25.85M
derived: sum of 4 quarters · filed 2022-02-14
2020-09-30$3.66M
10-Q · filed 2021-11-15
$11.05M
derived: sum of 2 quarters · filed 2021-11-15
$16.76M
derived: sum of 3 quarters · filed 2021-11-15
$22.42M
derived: sum of 4 quarters · filed 2021-11-15
2020-06-30$7.39M
10-K · filed 2020-09-25
$13.10M
derived: sum of 2 quarters · filed 2021-05-14
$18.76M
derived: sum of 3 quarters · filed 2021-05-14
-$23.61M
10-K · filed 2021-09-28
$23.72M
10-K · filed 2020-09-25
2020-03-31$5.71M
10-Q · filed 2021-05-14
$11.37M
derived: sum of 2 quarters · filed 2021-05-14
$16.33M
10-Q · filed 2021-05-14
$24.41M
derived: sum of 4 quarters · filed 2021-05-14
2019-12-31$5.66M
10-Q · filed 2021-02-16
$10.62M
10-Q · filed 2021-02-16
$18.70M
derived: sum of 3 quarters · filed 2021-02-16
$24.46M
derived: sum of 4 quarters · filed 2021-02-16
2019-09-30$4.96M
10-Q · filed 2020-11-16
$13.04M
derived: sum of 2 quarters · filed 2020-11-16
$18.80M
derived: sum of 3 quarters · filed 2020-11-16
$23.85M
derived: sum of 4 quarters · filed 2020-11-16
2019-06-30$8.08M
10-K · filed 2020-09-25
$8.08K
10-K · filed 2019-09-12
$13.84M
derived: sum of 2 quarters · filed 2020-09-25
$18.89M
derived: sum of 3 quarters · filed 2020-09-25
$24.56M
10-K · filed 2020-09-25
2019-03-31$5.76M
10-K · filed 2020-09-25
$5.76M
10-Q · filed 2019-05-09
$10.81M
derived: sum of 2 quarters · filed 2020-09-25
$16.48M
10-Q · filed 2020-05-11
$16.48M
derived: sum of 4 quarters · filed 2020-09-25
2018-12-31$5.05M
10-K · filed 2020-09-25
$5.05M
10-Q · filed 2019-02-11
$10.71M
10-Q · filed 2020-02-10
$10.72M
derived: sum of 3 quarters · filed 2020-09-25
$10.73M
derived: sum of 4 quarters · filed 2020-09-25
2018-09-30$5.66M
10-K · filed 2020-09-25
$5.66M
10-Q · filed 2018-11-09
$5.67M
derived: sum of 2 quarters · filed 2020-09-25
$5.68M
derived: sum of 3 quarters · filed 2020-09-25
$5.69M
derived: sum of 4 quarters · filed 2020-09-25
2018-06-30$8.35K
10-K · filed 2019-09-12
$17.83K
derived: sum of 2 quarters · filed 2019-09-12
$25.50K
derived: sum of 3 quarters · filed 2019-09-12
$41.21M
10-K · filed 2019-09-12
2018-03-31$9.48K
10-K · filed 2019-09-12
$9.48M
10-Q · filed 2018-05-14
$17.15K
derived: sum of 2 quarters · filed 2019-09-12
$32.86M
10-Q · filed 2019-05-09
$52.44K
derived: sum of 4 quarters · filed 2019-09-12
2017-12-31$7.67K
10-K · filed 2019-09-12
$7.67M
10-Q · filed 2018-02-12
$23.38M
10-Q · filed 2019-02-11
$42.96K
derived: sum of 3 quarters · filed 2019-09-12
$56.80K
derived: sum of 4 quarters · filed 2019-09-12
2017-09-30$15.71K
10-K · filed 2019-09-12
$15.71M
10-Q · filed 2017-11-13
$35.29K
derived: sum of 2 quarters · filed 2019-09-12
$49.13K
derived: sum of 3 quarters · filed 2019-09-12
$58.57K
derived: sum of 4 quarters · filed 2019-09-12
2017-06-30$19.58K
10-K · filed 2018-09-13
$33.42K
derived: sum of 2 quarters · filed 2018-09-13
$42.86K
derived: sum of 3 quarters · filed 2018-09-13
$41.21M
10-K · filed 2020-09-25
$55.29M
10-K · filed 2017-09-25
2017-03-31$13.84K
10-K · filed 2018-09-13
$13.84M
10-Q · filed 2017-05-15
$23.28K
derived: sum of 2 quarters · filed 2018-09-13
$35.71M
10-Q · filed 2018-05-14
$48.45K
derived: sum of 4 quarters · filed 2018-09-13
2016-12-31$9.44K
10-K · filed 2018-09-13
$9.44M
10-Q · filed 2017-02-10
$21.88M
10-Q · filed 2018-02-12
$34.61K
derived: sum of 3 quarters · filed 2018-09-13
$46.70K
derived: sum of 4 quarters · filed 2018-09-13
2016-09-30$12.44K
10-K · filed 2018-09-13
$12.44M
10-Q · filed 2016-11-14
$25.17K
derived: sum of 2 quarters · filed 2018-09-13
$37.26K
derived: sum of 3 quarters · filed 2018-09-13
$49.89K
derived: sum of 4 quarters · filed 2018-09-13
2016-06-30$12.74K
10-K · filed 2017-09-25
$24.82K
derived: sum of 2 quarters · filed 2017-09-25
$37.45K
derived: sum of 3 quarters · filed 2017-09-25
$49.25M
10-K · filed 2018-09-13
2016-03-31$12.09K
10-K · filed 2017-09-25
$12.09M
10-Q · filed 2016-05-16
$24.71K
derived: sum of 2 quarters · filed 2017-09-25
$36.51M
10-Q · filed 2017-05-15
$48.29K
derived: sum of 4 quarters · filed 2017-09-25
2015-12-31$12.63K
10-K · filed 2017-09-25
$12.63M
10-Q · filed 2016-02-12
$24.43M
10-Q · filed 2017-02-10
$36.21K
derived: sum of 3 quarters · filed 2017-09-25
$44.93K
derived: sum of 4 quarters · filed 2017-09-25
2015-09-30$11.80K
10-K · filed 2017-09-25
$11.80M
10-Q · filed 2015-11-12
$23.58K
derived: sum of 2 quarters · filed 2017-09-25
$32.30K
derived: sum of 3 quarters · filed 2017-09-25
$38.00K
derived: sum of 4 quarters · filed 2017-09-25
2015-06-30$11.78K
10-K · filed 2016-09-19
$20.50K
derived: sum of 2 quarters · filed 2016-09-19
$26.20K
derived: sum of 3 quarters · filed 2016-09-19
$30.24M
10-K · filed 2017-09-25
2015-03-31$8.72K
10-K · filed 2016-09-19
$8.72M
10-Q · filed 2015-05-12
$14.42K
derived: sum of 2 quarters · filed 2016-09-19
$18.46M
10-Q · filed 2016-05-16
$22.78K
derived: sum of 4 quarters · filed 2016-09-19
2014-12-31$5.70K
10-K · filed 2016-09-19
$5.70M
10-Q · filed 2015-02-12
$9.74M
10-Q · filed 2016-02-12
$14.06K
derived: sum of 3 quarters · filed 2016-09-19
$17.42K
derived: sum of 4 quarters · filed 2016-09-19
2014-09-30$4.04K
10-K · filed 2016-09-19
$4.04M
10-Q · filed 2014-11-14
$8.36K
derived: sum of 2 quarters · filed 2016-09-19
$11.72K
derived: sum of 3 quarters · filed 2016-09-19
$15.33K
derived: sum of 4 quarters · filed 2016-09-19
2014-06-30$4.32K
10-K · filed 2015-09-18
$4.32M
10-K · filed 2014-09-12
$7.68K
derived: sum of 2 quarters · filed 2015-09-18
$11.29K
derived: sum of 3 quarters · filed 2015-09-18
$15.79M
10-K · filed 2016-09-19
2014-03-31$3.36K
10-K · filed 2015-09-18
$3.36M
10-Q · filed 2014-05-12
$6.97K
derived: sum of 2 quarters · filed 2015-09-18
$11.47M
10-Q · filed 2015-05-12
$4.73M
derived: sum of 4 quarters · filed 2015-09-18
2013-12-31$3.61K
10-K · filed 2015-09-18
$3.61M
10-Q · filed 2014-02-14
$8.10M
10-Q · filed 2015-02-12
$4.73M
derived: sum of 3 quarters · filed 2015-09-18
$8.75M
derived: sum of 4 quarters · filed 2015-09-18
2013-09-30$4.49K
10-K · filed 2015-09-18
$4.49M
10-Q · filed 2013-11-13
$4.72M
derived: sum of 2 quarters · filed 2015-09-18
$8.75M
derived: sum of 3 quarters · filed 2015-09-18
$12.20M
derived: sum of 4 quarters · filed 2015-09-18
2013-06-30$4.72M
10-K · filed 2014-09-12
$8.74M
derived: sum of 2 quarters · filed 2014-09-12
$12.19M
derived: sum of 3 quarters · filed 2014-09-12
$15.60M
10-K · filed 2015-09-18
2013-03-31$4.02M
10-K · filed 2014-09-12
$4.02M
10-Q · filed 2013-05-13
$7.47M
derived: sum of 2 quarters · filed 2014-09-12
$10.88M
10-Q · filed 2014-05-12
$16.58M
derived: sum of 4 quarters · filed 2014-09-12
2012-12-31$3.45M
10-K · filed 2014-09-12
$3.45M
10-Q · filed 2013-02-13
$6.85M
10-Q · filed 2014-02-14
$12.55M
derived: sum of 3 quarters · filed 2014-09-12
$18.60M
derived: sum of 4 quarters · filed 2014-09-12
2012-09-30$3.40M
10-K · filed 2014-09-12
$3.40M
10-Q · filed 2012-11-14
$9.11M
derived: sum of 2 quarters · filed 2014-09-12
$15.16M
derived: sum of 3 quarters · filed 2014-09-12
$18.87M
derived: sum of 4 quarters · filed 2014-09-12
2012-06-30$5.70M
10-K · filed 2013-09-27
$11.75M
derived: sum of 2 quarters · filed 2013-09-27
$15.46M
derived: sum of 3 quarters · filed 2013-09-27
$18.86M
10-K · filed 2014-09-12
2012-03-31$6.05M
10-K · filed 2013-09-27
$6.05M
10-Q · filed 2012-05-14
$9.76M
derived: sum of 2 quarters · filed 2013-09-27
$13.16M
10-Q · filed 2013-05-13
$17.90M
derived: sum of 4 quarters · filed 2013-09-27
2011-12-31$3.71M
10-K · filed 2013-09-27
$3.71M
10-Q · filed 2012-02-14
$7.11M
10-Q · filed 2013-02-13
$11.85M
derived: sum of 3 quarters · filed 2013-09-27
$14.53M
derived: sum of 4 quarters · filed 2013-09-27
2011-09-30$3.39M
10-K · filed 2013-09-27
$3.39M
10-Q · filed 2011-11-14
$8.14M
derived: sum of 2 quarters · filed 2013-09-27
$10.81M
derived: sum of 3 quarters · filed 2013-09-27
$13.69M
derived: sum of 4 quarters · filed 2013-09-27
2011-06-30$4.74M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-27
$7.42M
derived: sum of 2 quarters · filed 2013-09-27
$10.29M
derived: sum of 3 quarters · filed 2013-09-27
$15.13M
10-K · filed 2013-09-27
2011-03-31$2.68M
10-Q · filed 2012-05-14
$5.55M
derived: sum of 2 quarters · filed 2012-05-14
$10.39M
10-Q · filed 2012-05-14
2010-12-31$2.87M
10-Q · filed 2012-02-14
$7.71M
10-Q · filed 2012-02-14
2010-09-30$4.83M
10-Q · filed 2011-11-14
2010-06-30$17.20M
10-K · filed 2012-09-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
Lipocine Inc. (LPCN)United States$0.017B-1.79
Allarity Therapeutics, Inc. (ALLR)United States$0.017B-1.66
Pasithea Therapeutics Corp. (KTTA)United States$0.017B-0.81
Biofrontera Inc. (BFRI)United States$0.018B-2.13
Korsana Biosciences, Inc. (CYCN)United States$0.016B
Citius Pharmaceuticals, Inc. (CTXR)United States$0.016B-133.06
Rocket One Inc. (RKTO)United States$0.019B
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)United States$0.019B-0.31
Lantern Pharma Inc. (LTRN)United States$0.015B-2.87
Anebulo Pharmaceuticals, Inc. (ANEB)United States$0.015B